Latest News

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

Key Insights The projected fair value for Hyundai Rotem is ₩240,679 based on 2 Stage Free Cash Flow to Equity With...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Key Insights Using the 2 Stage Free Cash Flow to Equity, SHIFT UP fair value estimate is ₩43,935 With ₩38,050 share...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Even though Three F Co.,Ltd. ( TSE:7544 ) posted strong earnings, investors appeared to be underwhelmed. We have done...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, NatureCellLtd...

In recent days, a shareholder rights law firm began investigating whether RXO, Inc. or certain of its officers and directors violated federal securities laws by misrepresenting or failing to timely disclose material information to investors. This development coincides with commentary on RXO’s rising costs and declining earnings, which has heightened investor concerns over the company’s financial transparency and profitability. The launch of this legal investigation into RXO's disclosure...

Adaptive Biotechnologies (ADPT) is seeing renewed investor attention, especially as its stock has gained over 27% in the past month and jumped by nearly 57% over the past 3 months. These moves come amid rising interest in the company’s advancements and financial results, as investors look for additional clues about its long-term potential. See our latest analysis for Adaptive Biotechnologies. Momentum has been building for Adaptive Biotechnologies, with a string of positive developments...

Some Kitahama Capital Partners Co.,Ltd. ( TSE:2134 ) shareholders are probably rather concerned to see the share price...

Revolution Medicines announced that the U.S. FDA has granted a non-transferrable Commissioner's National Priority Voucher for its investigational cancer therapy daraxonrasib, which is currently being studied in two global Phase 3 clinical trials for previously treated metastatic pancreatic ductal adenocarcinoma and non-small cell lung cancer. This milestone spotlights growing recognition of the significant unmet medical need in RAS-driven cancers and the potential for daraxonrasib to address...

MakeMyTrip Limited recently announced that it will report its fiscal 2026 second quarter financial and operating results before markets open on October 28, 2025, with a live management discussion and replay available through its Investor Relations website. Investor attention is centering on MakeMyTrip due to analyst projections of significant year-over-year growth in both earnings per share and revenue for the upcoming quarter. We'll explore how strong expectations for MakeMyTrip's quarterly...

Goldman Sachs recently upgraded Kaspi.kz (NasdaqGS:KSPI), highlighting the company’s current valuation discount despite regulatory hurdles and higher interest rates. Investors are watching closely ahead of the upcoming earnings call. See our latest analysis for Kaspi.kz. Kaspi.kz has weathered a volatile year, with its share price dropping 26.4% since January and a one-year total shareholder return of -35.3%. This reflects the market’s caution amid regulatory and interest rate headwinds...

Earlier this month, Newmark Group expanded its European debt, equity, and structured finance division by appointing Andrew Allen, Hoong Wey Woon, Max Hagelstein, and Phil Creed to senior leadership roles, enhancing expertise across sectors such as data centres, residential, and industrial real estate. This move reflects a major investment in broadening Newmark's presence and capabilities in European markets, emphasizing cross-border collaboration and sector expertise. We'll assess how...

MP Materials, the leading US producer of rare earths, has drawn fresh attention after the Department of Defense made a sizable investment and signed a landmark partnership with the company. This comes as US-China tensions highlight America’s push to secure key minerals independently. See our latest analysis for MP Materials. MP Materials has seen its share price rocket nearly 393% since the start of the year, propelled by a wave of strategic wins and surging demand for reliable U.S. rare...

Abercrombie & Fitch recently launched the "In Her Own League" campaign as part of its NFL partnership, spotlighting women with significant achievements tied to football culture and styling them in the brand's fall collection at game days and events throughout the season. This initiative underscores Abercrombie & Fitch's push to reposition itself as a modern lifestyle brand by authentically engaging with sports, culture, and identity, reflecting broader ambitions for cultural relevance and...

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...

Vitec Software Group AB reported third quarter and nine-month 2025 earnings, with sales increasing to SEK773.22 million and SEK2.37 billion, respectively, while net income and earnings per share saw minor declines year-over-year. An interesting detail is that recurring revenue accounted for 90% of total sales, highlighting the company’s focus on stable, reliable income streams. Next, we'll explore how Vitec’s international expansion and resilient recurring revenue base inform its current...

On October 2, 2025, The Geo Group announced it had entered into a joint venture to manage the 1,310-bed North Florida Detention Facility in Baker County under contract with the state of Florida, with GEO as the lead manager. This agreement significantly increases GEO's managed capacity in the southeastern United States and highlights its ongoing expansion in state-contracted detention services. We’ll look at how the addition of this Florida facility could influence GEO Group’s growth outlook...